Cambridge Nutritional Science’s (CNSL) has provided a trading update for the year ended 31 March 2025. Total income is expected to be c.£11.1m (FY24: £9.9m) representing a 12% YoY increase. FY25 underlying revenues are expected to be £8.3m, c£0.5m below our estimates of £8.8m yet despite the softer sales figures, FY25E adjusted EBITDA remains unaffected and is expected to be in-line with our current expectations at £0.4m (FY24: £0.2m). CNS has effectively drawn a line under its legacy issues, co ....
